These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5429830)

  • 1. [The effect of noracycline administered in menstruation disorders on certain biological functions of the female organism. Effects on the protein metabolism].
    Jabloński K; Giermańska T; Filc-Bauer A
    Pol Tyg Lek; 1970 May; 25(18):635-7. PubMed ID: 5429830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of noracycline administered in menstruation disorders on various biological functions of the female organism. The secretion of ovarian hormones].
    Jabloński K; Zymek-Giermańska T; Filc-Bauer A
    Pol Tyg Lek; 1971 Apr; 26(14):505-7. PubMed ID: 5581640
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of noracycline administered for dysmenorrhea on certain biologic functions of the female organism. Its effect on electrolyte metabolism].
    Jabloński K; Giermańska T; Filc-Bauer A
    Pol Tyg Lek; 1970 Nov; 25(47):1789-92. PubMed ID: 5484511
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of noracycline administered in menstrual disturbances on certain biological functions in the female organism].
    Jabloński K; Giermańska T; Filc-Bauer A
    Pol Tyg Lek; 1970 Sep; 25(36):1361-3. PubMed ID: 5470622
    [No Abstract]   [Full Text] [Related]  

  • 5. [Handling of a synthetic progestative in a psychiatric milieu].
    Dubor P; Favre-Tissot M; Guyotat J; Haour P; Simonnet ; Vantheemsche G
    J Med Lyon; 1966 Oct; 47(106):1379-85. PubMed ID: 5928220
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of dysfunctional uterine hemorrhages and amenorrheas using a progestagen-estrogen combination].
    Brehm H; Karsznia R; Prinz W; Schmidt G
    Med Monatsschr; 1972 Dec; 26(12):577-9. PubMed ID: 4663633
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment with ovariostatic drugs in premenopausal syndromes. Cytological control].
    Subrizi DA; Pieroni G
    Riv Ostet Ginecol; 1966 Jun; 21(6):320-6. PubMed ID: 5963561
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of a synthetic progestagen at low doses].
    Gaudefroy M
    Gynecol Prat; 1966; 17():337-43. PubMed ID: 5987259
    [No Abstract]   [Full Text] [Related]  

  • 9. [Estroprogestinic associations in the preclimacteric syndrome: blood coagulation problems].
    Schubert L; Giarola P; Gibelli A; Iurlaro F
    G Gerontol; 1969 Nov; 17(11):1059-66. PubMed ID: 5397790
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with gestagen therapy of various gynecologic diseases].
    György G; László J
    Orv Hetil; 1967 Jun; 108(25):1169-71. PubMed ID: 6077686
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hormonal treatment of juvenile menstruation disorders].
    Sas M
    Fortschr Med; 1974 May; 92(15):641-2. PubMed ID: 4829461
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical investigations on the usefulness of Lyndiol for contraceptive and therapeutic purposes].
    Liebhart S; Trebicka-Kwiatkowska B
    Endokrynol Pol; 1966; 17(6):717-28. PubMed ID: 5341992
    [No Abstract]   [Full Text] [Related]  

  • 13. A new progestogen-estrogen combination for gynecologic therapy and contraception.
    Linthorst G
    Int J Fertil; 1966; 11(1):35-45. PubMed ID: 5936282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experimentation with Ovanon].
    Durandeau A
    Rev Bras Med; 1968 Apr; 25(4):241-5. PubMed ID: 5747876
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tolerance of the gestagen-estrogen combination Noracyclin in contraception and gynecologic indications].
    Willmes HG
    Med Klin; 1967 Jun; 62(24):951-4. PubMed ID: 5627276
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of sistometril on the LH excretion in the urine of women with menstruation disorders].
    Wawryk R; Samochowiec E; Krupa B; Lipski J
    Ginekol Pol; 1969 Aug; 40(8):903-10. PubMed ID: 5820768
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action duration of lynestrenol as a component of an anticontraceptive agent].
    Schmidt-Elmendorff H
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):352-5. PubMed ID: 5148892
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood glucose in women on Noracycline and Gestranol].
    Jabloński K; Giermańska T; Filc-Bauer A
    Pol Tyg Lek; 1972 Oct; 27(43):1676-8. PubMed ID: 4639621
    [No Abstract]   [Full Text] [Related]  

  • 19. A new oral contraceptive with a 7 plus 15 sequential formulation.
    Brosens I; Van Assche A; Wijnants P
    Arzneimittelforschung; 1970 Feb; 20(2):236-7. PubMed ID: 5467468
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lynestrenol in gynecologic pathology].
    Minucci D; Sciarretta A
    Riv Ital Ginecol; 1969 Dec; 53(12):755-69. PubMed ID: 5405505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.